Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Sheng Guo

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Biological Therapy|June 4, 2004
Vaccinia as a vector for gene deliveryZ Sheng Guo, David L Bartlett
Biomolecular Concepts|May 12, 2015
Epigenetic drugs for cancer treatment and prevention: mechanisms of actionXiao-Dan Yu, Z Sheng Guo
Biochimica Et Biophysica Acta|March 11, 2008
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesZ Sheng Guo, Stephen H Thorne, David L Bartlett
Molecular Cancer|May 26, 2011
Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growthQiang Li, Mark E O'Malley, David L Bartlett, et al.
Nature Communications|March 28, 2017
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacyZuqiang Liu, Roshni Ravindranathan, Pawel Kalinski, et al.
American Journal of Cancer Research|January 30, 2013
Life after death: targeting high mobility group box 1 in emergent cancer therapiesZ Sheng Guo, Zuqiang Liu, David L Bartlett, et al.
Trends in Molecular Medicine|August 12, 2008
Gene transfer: the challenge of regulated gene expressionZ Sheng Guo, Qiang Li, David L Bartlett, et al.
Oncoimmunology|May 4, 2016
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacyZuqiang Liu, Roshni Ravindranathan, Jun Li, et al.
Molecular Pharmacology|August 15, 2009
Three epigenetic drugs up-regulate homeobox gene Rhox5 in cancer cells through overlapping and distinct molecular mechanismsQiang Li, David L Bartlett, Michael C Gorry, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2013
T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapyFeng Yu, Xingbing Wang, Z Sheng Guo, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Biological Therapy|June 4, 2004
Vaccinia as a vector for gene deliveryZ Sheng Guo, David L Bartlett
Biomolecular Concepts|May 12, 2015
Epigenetic drugs for cancer treatment and prevention: mechanisms of actionXiao-Dan Yu, Z Sheng Guo
Biochimica Et Biophysica Acta|March 11, 2008
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesZ Sheng Guo, Stephen H Thorne, David L Bartlett
Molecular Cancer|May 26, 2011
Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growthQiang Li, Mark E O'Malley, David L Bartlett, et al.
Nature Communications|March 28, 2017
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacyZuqiang Liu, Roshni Ravindranathan, Pawel Kalinski, et al.
American Journal of Cancer Research|January 30, 2013
Life after death: targeting high mobility group box 1 in emergent cancer therapiesZ Sheng Guo, Zuqiang Liu, David L Bartlett, et al.
Trends in Molecular Medicine|August 12, 2008
Gene transfer: the challenge of regulated gene expressionZ Sheng Guo, Qiang Li, David L Bartlett, et al.
Oncoimmunology|May 4, 2016
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacyZuqiang Liu, Roshni Ravindranathan, Jun Li, et al.
Molecular Pharmacology|August 15, 2009
Three epigenetic drugs up-regulate homeobox gene Rhox5 in cancer cells through overlapping and distinct molecular mechanismsQiang Li, David L Bartlett, Michael C Gorry, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2013
T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapyFeng Yu, Xingbing Wang, Z Sheng Guo, et al.
Pageof 3